FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20230426E00035
1. Date of relevant event: 21/04/2023
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02192
4. Name of listed corporation: Medlive Technology Co., Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 719,789,000
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Tian
(Other names) Liping
10. Name of director (Chinese): 田立平 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1303There has been a change in nature of your interest in the shares because:
you have exercised rights to the shares under equity derivatives
 
2101Beneficial owner
 
2101Beneficial owner
 
600,000         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position278,134,50038.70
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position278,134,50038.64
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position267,540,000
2101Beneficial owner
Long position10,494,500
2202Interest of your spouse
Long position100,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
15/07/202315/07/2026CNY0CNY0.380  2,534,500
Long position
4105Unlisted derivatives - Physically settled
15/07/202315/07/2026CNY0CNY0.380  25,000
Long position
4105Unlisted derivatives - Physically settled
15/07/202415/07/2026CNY0CNY0.380  2,534,500
Long position
4105Unlisted derivatives - Physically settled
15/07/202415/07/2026CNY0CNY0.380  25,000
Long position
4105Unlisted derivatives - Physically settled
15/07/202515/07/2026CNY0CNY0.380  2,534,500
Long position
4105Unlisted derivatives - Physically settled
15/07/202515/07/2026CNY0CNY0.380  25,000
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseZhang Xiaofeng
Long position100,000
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Tiantian Co., Limited25 Guzman Street, Belama Phase 1, Belize City, Belize (Belize)Tian Liping48.00Y
Long position267,540,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: On 21 April 2023, Tian Liping exercised share options representing 600,000 underlying shares.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 26/04/2023
(dd/mm/yyyy)